{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:42:13Z","timestamp":1793814133375,"version":"4.6.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"DOI":"10.1186\/s13643-025-02947-4","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T02:34:46Z","timestamp":1768185286000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of different mRNA testing technologies with HPV DNA testing for predicting ASCUS triage and post-cone excision outcomes: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"15","author":[{"given":"Chao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaolan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"issue":"3","key":"2947_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"2947_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","volume":"135","author":"C Xia","year":"2022","unstructured":"Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135(5):584\u201390. https:\/\/doi.org\/10.1097\/CM9.0000000000002108. Published 2022 Feb 9.","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"2947_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1001\/jamapediatrics.2021.4807","volume":"176","author":"T Tabibi","year":"2022","unstructured":"Tabibi T, Barnes JM, Shah A, Osazuwa-Peters N, Johnson KJ, Brown DS. Human papillomavirus vaccination and trends in cervical cancer incidence and mortality in the US. JAMA Pediatr. 2022;176(3):313\u20136. https:\/\/doi.org\/10.1001\/jamapediatrics.2021.4807.","journal-title":"JAMA Pediatr"},{"issue":"9590","key":"2947_CR4","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S0140-6736(07)61416-0","volume":"370","author":"M Schiffman","year":"2007","unstructured":"Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890\u2013907. https:\/\/doi.org\/10.1016\/S0140-6736(07)61416-0.","journal-title":"Lancet"},{"issue":"2 Suppl","key":"2947_CR5","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.ygyno.2010.01.024","volume":"117","author":"M Stanley","year":"2010","unstructured":"Stanley M. Pathology and epidemiology of HPV infection in females. Gynecol Oncol. 2010;117(2 Suppl):S5-10. https:\/\/doi.org\/10.1016\/j.ygyno.2010.01.024. PMID: 20304221.","journal-title":"Gynecol Oncol"},{"issue":"6006","key":"2947_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/314111a0","volume":"314","author":"E Schwarz","year":"1985","unstructured":"Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A, et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature. 1985;314(6006):111\u20134. https:\/\/doi.org\/10.1038\/314111a0.","journal-title":"Nature"},{"issue":"4","key":"2947_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006211","volume":"13","author":"AA McBride","year":"2017","unstructured":"McBride AA, Warburton A. The role of integration in oncogenic progression of HPV-associated cancers. PLoS Pathog. 2017;13(4):e1006211. https:\/\/doi.org\/10.1371\/journal.ppat.1006211.","journal-title":"PLoS Pathog"},{"key":"2947_CR8","unstructured":"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. 2nd ed. Geneva: World Health Organization; 2021. PMID: 34314129."},{"issue":"3","key":"2947_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/LGT.0b013e31824ca9d5.PMID:22418039;PMCID:PMC3915715","volume":"16","author":"D Saslow","year":"2012","unstructured":"Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain JM, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis. 2012;16(3):175\u2013204. https:\/\/doi.org\/10.1097\/LGT.0b013e31824ca9d5.PMID:22418039;PMCID:PMC3915715.","journal-title":"J Low Genit Tract Dis"},{"issue":"9","key":"2947_CR10","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.2217\/fmb.11.87","volume":"6","author":"VV Sahasrabuddhe","year":"2011","unstructured":"Sahasrabuddhe VV, Luhn P, Wentzensen N. Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Future Microbiol. 2011;6(9):1083\u201398. https:\/\/doi.org\/10.2217\/fmb.11.87.","journal-title":"Future Microbiol"},{"issue":"9","key":"2947_CR11","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju241","volume":"106","author":"Q Tian","year":"2014","unstructured":"Tian Q, Li Y, Wang F, Li Y, Xu J, Shen Y, et al. Microrna detection in cervical exfoliated cells as a triage for human papillomavirus-positive women. J Natl Cancer Inst. 2014;106(9):dju241. https:\/\/doi.org\/10.1093\/jnci\/dju241.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"2947_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-017-0720-x","volume":"14","author":"N Fontecha","year":"2017","unstructured":"Fontecha N, Nieto MC, And\u00eda D, Cisterna R, Basaras M. RNA extraction method is crucial for human papillomavirus E6\/E7 oncogenes detection. Virol J. 2017;14(1):50. https:\/\/doi.org\/10.1186\/s12985-017-0720-x.","journal-title":"Virol J"},{"issue":"10","key":"2947_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164892","volume":"11","author":"VS Mariano","year":"2016","unstructured":"Mariano VS, Lorenzi AT, Scapulatempo-Neto C, Stein MD, Resende JC, Antoniazzi M, et al. A low-cost HPV immunochromatographic assay to detect high-grade cervical intraepithelial neoplasia. PLoS ONE. 2016;11(10):e0164892. https:\/\/doi.org\/10.1371\/journal.pone.0164892.","journal-title":"PLoS ONE"},{"issue":"9","key":"2947_CR14","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/jmv.24199","volume":"87","author":"S Duvlis","year":"2015","unstructured":"Duvlis S, Popovska-Jankovic K, Arsova ZS, Memeti S, Popeska Z, Plaseska-Karanfilska D. HPV E6\/E7 mRNA versus HPV DNA biomarker in cervical cancer screening of a group of Macedonian women. J Med Virol. 2015;87(9):1578\u201386. https:\/\/doi.org\/10.1002\/jmv.24199. 2015 Apr 16. PMID: 25880030.","journal-title":"J Med Virol"},{"issue":"43","key":"2947_CR15","first-page":"3432","volume":"94","author":"X Zhao","year":"2014","unstructured":"Zhao X, Cui Y, Jiang S, Meng Y, Liu A, Wei L, et al. Comparative study of HR HPV E6\/E7 mRNA and HR-HPV DNA in cervical cancer screening. Zhonghua Yi Xue Za Zhi. 2014;94(43):3432\u20135 Chinese PMID: 25622677.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"6","key":"2947_CR16","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/jmv.23544","volume":"85","author":"S Perez Castro","year":"2013","unstructured":"Perez Castro S, I\u00f1arrea Fern\u00e1ndez A, Lamas Gonz\u00e1lez MJ, Sar\u00e1n Diez MT, Cid Lama A, Alvarez Mart\u00edn MJ, et al. Human papillomavirus (HPV) E6\/E7 mrna as a triage test after detection of HPV 16 and HPV 18 dna. J Med Virol. 2013;85(6):1063\u20138. https:\/\/doi.org\/10.1002\/jmv.23544.","journal-title":"J Med Virol"},{"issue":"1","key":"2947_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/dc.25229","volume":"52","author":"L Chen","year":"2024","unstructured":"Chen L, Zhu K, Chen H, Liu Q, Zhang X, Zhou X, et al. Correlation of immediate prevalence of cervical squamous cell precancers and cancers with HPV genotype and age in women with LSIL cytology: a retrospective analysis of 1617 cases. Diagn Cytopathol. 2024;52(1):10\u20135. https:\/\/doi.org\/10.1002\/dc.25229.","journal-title":"Diagn Cytopathol"},{"issue":"7","key":"2947_CR18","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/S1470-2045(22)00294-7","volume":"23","author":"M Arbyn","year":"2022","unstructured":"Arbyn M, Simon M, de Sanjos\u00e9 S, Clarke MA, Poljak M, Rezhake R, et al. Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis. Lancet Oncol. 2022;23(7):950\u201360. https:\/\/doi.org\/10.1016\/S1470-2045(22)00294-7.","journal-title":"Lancet Oncol"},{"issue":"1","key":"2947_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13027-020-0278-x","volume":"15","author":"A Derbie","year":"2020","unstructured":"Derbie A, Mekonnen D, Woldeamanuel Y, Van Ostade X, Abebe T. HPV E6\/E7 mRNA test for the detection of high grade cervical intraepithelial neoplasia (CIN2+): a systematic review. Infect Agent Cancer. 2020;15(1):9. https:\/\/doi.org\/10.1186\/s13027-020-0278-x.","journal-title":"Infect Agent Cancer"},{"issue":"8","key":"2947_CR20","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529\u201336. https:\/\/doi.org\/10.7326\/0003-4819-155-8-201110180-00009.","journal-title":"Ann Intern Med"},{"key":"2947_CR21","doi-asserted-by":"publisher","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. https:\/\/doi.org\/10.1136\/bmj.d5928. PMID: 22008217; PMCID: PMC3196245.","DOI":"10.1136\/bmj.d5928"},{"key":"2947_CR22","doi-asserted-by":"publisher","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. Published 2016 Oct 12. https:\/\/doi.org\/10.1136\/bmj.i4919","DOI":"10.1136\/bmj.i4919"},{"issue":"1","key":"2947_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13690-021-00747-5","volume":"80","author":"VN Nyaga","year":"2022","unstructured":"Nyaga VN, Arbyn M. Metadta: a Stata command for meta-analysis and meta-regression of diagnostic test accuracy data - a tutorial. Arch Public Health. 2022;80(1):95. https:\/\/doi.org\/10.1186\/s13690-021-00747-5. Erratum.In:ArchPublicHealth.2022Sep27;80(1):216.doi:10.1186\/s13690-022-00953-9.PMID:35351195;PMCID:PMC8962039.","journal-title":"Arch Public Health"},{"issue":"10","key":"2947_CR24","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3760\/cma.j.cn112152-20190516-00311","volume":"43","author":"Z Guo","year":"2021","unstructured":"Guo Z, Zhao DM, Zhang SK, et al. Zhonghua Zhong Liu Za Zhi. 2021;43(10):1094\u20139. https:\/\/doi.org\/10.3760\/cma.j.cn112152-20190516-00311.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"2","key":"2947_CR25","doi-asserted-by":"publisher","first-page":"144.e1","DOI":"10.1016\/j.ajog.2012.12.003","volume":"208","author":"MH Stoler","year":"2013","unstructured":"Stoler MH, Wright TC Jr, Cuzick J, et al. APTIMA HPV assay performance in women with atypical squamous cells of undetermined significance cytology results. Am J Obstet Gynecol. 2013;208(2):144.e1-144.e1448. https:\/\/doi.org\/10.1016\/j.ajog.2012.12.003.","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2947_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4103\/2096-2924.248485","volume":"2","author":"Q Wang","year":"2018","unstructured":"Wang Q, Zhu C, Chen L, et al. Clinical value of human papillomavirus E6\/E7 mRNA testing in patients with atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion [J]. Reprod Dev Med. 2018;2(3):157\u201361.","journal-title":"Reprod Dev Med"},{"issue":"6","key":"2947_CR27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1365-2303.2011.00923.x","volume":"23","author":"M Waldstrom","year":"2012","unstructured":"Waldstrom M, Ornskov D. Comparison of the clinical performance of an HPV mRNA test and an HPV DNA test in triage of atypical squamous cells of undetermined significance (ASC-US). Cytopathology. 2012;23(6):389\u201395. https:\/\/doi.org\/10.1111\/j.1365-2303.2011.00923.x.","journal-title":"Cytopathology"},{"issue":"1","key":"2947_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5492-9","volume":"19","author":"Y Zhu","year":"2019","unstructured":"Zhu Y, Ren C, Yang L, Zhang X, Liu L, Wang Z. Performance of p16\/Ki67 immunostaining, HPV E6\/E7 mRNA testing, and HPV DNA assay to detect high-grade cervical dysplasia in women with ASCUS. BMC Cancer. 2019;19(1):271. https:\/\/doi.org\/10.1186\/s12885-019-5492-9. Published 2019 Mar 27.","journal-title":"BMC Cancer"},{"issue":"7","key":"2947_CR29","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1128\/JCM.02570-10","volume":"49","author":"M Benevolo","year":"2011","unstructured":"Benevolo M, Vocaturo A, Caraceni D, et al. Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6\/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test. J Clin Microbiol. 2011;49(7):2643\u201350. https:\/\/doi.org\/10.1128\/JCM.02570-10.","journal-title":"J Clin Microbiol"},{"issue":"24","key":"2947_CR30","doi-asserted-by":"publisher","first-page":"10672","DOI":"10.26355\/eurrev_201912_19765","volume":"23","author":"A Frega","year":"2019","unstructured":"Frega A, Pavone M, Sesti F, et al. Sensitivity and specificity values of high-risk HPV DNA, p16\/ki-67 and HPV mRNA in young women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL). Eur Rev Med Pharmacol Sci. 2019;23(24):10672\u20137. https:\/\/doi.org\/10.26355\/eurrev_201912_19765.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"2947_CR31","doi-asserted-by":"publisher","first-page":"606","DOI":"10.11817\/j.issn.1672-7347.2016.06.009","volume":"41","author":"H Zhao","year":"2016","unstructured":"Zhao H, Shao H. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2016;41(6):606\u201311. https:\/\/doi.org\/10.11817\/j.issn.1672-7347.2016.06.009.","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"1","key":"2947_CR32","first-page":"99","volume":"25","author":"F Carcea","year":"2020","unstructured":"Carcea F, Daniilidis A, Vavoulidis E, Nasioutziki M, Papanikolaou A, Dinas K. A cohort retrospective study of high-risk HPV recurrence in Greek women after cervical lesion treatment through detection of viral E6\/E7 mRNA expression. J BUON. 2020;25(1):99\u2013107.","journal-title":"J BUON"},{"issue":"1","key":"2947_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jcv.2014.01.017","volume":"60","author":"A Frega","year":"2014","unstructured":"Frega A, Sesti F, Lombardi D, et al. Assessment of HPV-mRNA test to predict recurrent disease in patients previously treated for CIN 2\/3. J Clin Virol. 2014;60(1):39\u201343. https:\/\/doi.org\/10.1016\/j.jcv.2014.01.017.","journal-title":"J Clin Virol"},{"issue":"10","key":"2947_CR34","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1111\/jog.14976","volume":"47","author":"F Carcea","year":"2021","unstructured":"Carcea F, Vavoulidis E, Petousis S, et al. Diagnostic performance of HPV E6\/E7 mRNA testing towards HPV-DNA testing and p16\/Ki67 immunostaining as a biomarker of high-risk HPV recurrence in Greek women surgically treated for their cervical lesions. J Obstet Gynaecol Res. 2021;47(10):3607\u201317. https:\/\/doi.org\/10.1111\/jog.14976.","journal-title":"J Obstet Gynaecol Res"},{"issue":"2","key":"2947_CR35","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/JCM.02147-10","volume":"49","author":"S Ratnam","year":"2011","unstructured":"Ratnam S, Coutlee F, Fontaine D, Bentley J, Escott N, Ghatage P, et al. Aptima HPV E6\/E7 mRNA test is as sensitive as hybrid capture 2 assay but more specific at detecting cervical precancer and cancer. J Clin Microbiol. 2011;49(2):557\u201364. https:\/\/doi.org\/10.1128\/JCM.02147-10.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2947_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13000-021-01072-9.PMID:33608003;PMCID:PMC7896359","volume":"16","author":"C Hui","year":"2021","unstructured":"Hui C, Bai H, Liu J, Lu X, Wang S, Zhang Z, et al. Accuracy of HPV E6\/E7 mRNA examination using in situ hybridization in diagnosing cervical intraepithelial lesions. Diagn Pathol. 2021;16(1):13. https:\/\/doi.org\/10.1186\/s13000-021-01072-9.PMID:33608003;PMCID:PMC7896359.","journal-title":"Diagn Pathol"},{"issue":"4","key":"2947_CR37","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/bjc.2013.22","volume":"108","author":"J Cuzick","year":"2013","unstructured":"Cuzick J, Cadman L, Mesher D, et al. Comparing the performance of six human papillomavirus tests in a screening population. Br J Cancer. 2013;108(4):908\u201313. https:\/\/doi.org\/10.1038\/bjc.2013.22.","journal-title":"Br J Cancer"},{"issue":"9446","key":"2947_CR38","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/S0140-6736(04)17354-6","volume":"364","author":"AB Moscicki","year":"2004","unstructured":"Moscicki AB, Shiboski S, Hills NK, et al. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet. 2004;364(9446):1678\u201383. https:\/\/doi.org\/10.1016\/S0140-6736(04)17354-6.","journal-title":"Lancet"},{"key":"2947_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.909223","volume":"12","author":"Y Mo","year":"2022","unstructured":"Mo Y, Ma J, Zhang H, et al. Prophylactic and therapeutic HPV vaccines: current scenario and perspectives. Front Cell Infect Microbiol. 2022;12:909223. https:\/\/doi.org\/10.3389\/fcimb.2022.909223.","journal-title":"Front Cell Infect Microbiol"},{"issue":"8","key":"2947_CR40","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-156-8-201204170-00011","volume":"156","author":"G Ronco","year":"2012","unstructured":"Ronco G, Meijer CJ, Cuzick J, et al. Screening for cervical cancer. Ann Intern Med. 2012;156(8):604\u20136. https:\/\/doi.org\/10.7326\/0003-4819-156-8-201204170-00011.","journal-title":"Ann Intern Med"},{"key":"2947_CR41","doi-asserted-by":"publisher","unstructured":"Wentzensen N, Schiffman M, Palmer T, Arbyn M. Triage of HPV positive women in cervical cancer screening. J Clin Virol. 2016;76 Suppl 1(Suppl 1):S49-S55. https:\/\/doi.org\/10.1016\/j.jcv.2015.11.015","DOI":"10.1016\/j.jcv.2015.11.015"},{"issue":"2","key":"2947_CR42","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S1470-2045(12)70529-6","volume":"14","author":"F Carozzi","year":"2013","unstructured":"Carozzi F, Gillio-Tos A, Confortini M, et al. Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial. Lancet Oncol. 2013;14(2):168\u201376. https:\/\/doi.org\/10.1016\/S1470-2045(12)70529-6.","journal-title":"Lancet Oncol"},{"issue":"1","key":"2947_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/ajcp\/aqv019","volume":"145","author":"D Gustinucci","year":"2016","unstructured":"Gustinucci D, Giorgi Rossi P, Cesarini E, et al. Use of cytology, E6\/E7 mRNA, and p16INK4a-Ki-67 to define the management of human papillomavirus (HPV)-positive women in cervical cancer screening. Am J Clin Pathol. 2016;145(1):35\u201345. https:\/\/doi.org\/10.1093\/ajcp\/aqv019.","journal-title":"Am J Clin Pathol"},{"key":"2947_CR44","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jviromet.2013.10.032","volume":"196","author":"TY Liu","year":"2014","unstructured":"Liu TY, Xie R, Luo L, et al. Diagnostic validity of human papillomavirus E6\/E7 mRNA test in cervical cytological samples. J Virol Methods. 2014;196:120\u20135. https:\/\/doi.org\/10.1016\/j.jviromet.2013.10.032.","journal-title":"J Virol Methods"},{"issue":"2","key":"2947_CR45","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000358246","volume":"58","author":"JL Sauter","year":"2014","unstructured":"Sauter JL, Mount SL, St John TL, Wojewoda CM, Bryant RJ, Leiman G. Testing of integrated human papillomavirus mRNA decreases colposcopy referrals: could a change in human papillomavirus detection methodology lead to more cost-effective patient care? Acta Cytol. 2014;58(2):162\u20136. https:\/\/doi.org\/10.1159\/000358246.","journal-title":"Acta Cytol"},{"issue":"6","key":"2947_CR46","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.vaccine.2015.12.011","volume":"34","author":"M Fakhreldin","year":"2016","unstructured":"Fakhreldin M, Elmasry K. Improving the performance of reflex human papilloma virus (HPV) testing in triaging women with atypical squamous cells of undetermined significance (ASCUS): a restrospective study in a tertiary hospital in United Arab Emirates (UAE). Vaccine. 2016;34(6):823\u201330. https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.011.","journal-title":"Vaccine"},{"issue":"3","key":"2947_CR47","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/cncy.22103","volume":"127","author":"E Peeters","year":"2019","unstructured":"Peeters E, Wentzensen N, Bergeron C, Arbyn M. Meta-analysis of the accuracy of p16 or p16\/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+\/CIN3+ in triage of women with minor abnormal cytology. Cancer Cytopathol. 2019;127(3):169\u201380. https:\/\/doi.org\/10.1002\/cncy.22103.","journal-title":"Cancer Cytopathol"},{"issue":"12","key":"2947_CR48","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1002\/cncy.21325","volume":"121","author":"F Verdoodt","year":"2013","unstructured":"Verdoodt F, Szarewski A, Halfon P, Cuschieri K, Arbyn M. Triage of women with minor abnormal cervical cytology: meta-analysis of the accuracy of an assay targeting messenger ribonucleic acid of 5 high-risk human papillomavirus types. Cancer Cytopathol. 2013;121(12):675\u201387. https:\/\/doi.org\/10.1002\/cncy.21325.","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"2947_CR49","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1586\/14737159.2015.961915","volume":"15","author":"R Zappacosta","year":"2015","unstructured":"Zappacosta R, Gatta DM, Marinucci P, et al. Role of E6\/E7 mRNA test in the diagnostic algorithm of HPV-positive patients showing ASCUS and LSIL: clinical and economic implications in a publicly financed healthcare system. Expert Rev Mol Diagn. 2015;15(1):137\u201350. https:\/\/doi.org\/10.1586\/14737159.2015.961915.","journal-title":"Expert Rev Mol Diagn"},{"issue":"20","key":"2947_CR50","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/jnci\/djt235","volume":"105","author":"H Ikenberg","year":"2013","unstructured":"Ikenberg H, Bergeron C, Schmidt D, et al. Screening for cervical cancer precursors with p16\/Ki-67 dual-stained cytology: results of the PALMS study. J Natl Cancer Inst. 2013;105(20):1550\u20137. https:\/\/doi.org\/10.1093\/jnci\/djt235.","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"2947_CR51","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1158\/1055-9965.EPI-14-0347","volume":"23","author":"LM De Strooper","year":"2014","unstructured":"De Strooper LM, Hesselink AT, Berkhof J, et al. Combined CADM1\/MAL methylation and cytology testing for colposcopy triage of high-risk HPV-positive women. Cancer Epidemiol Biomarkers Prev. 2014;23(9):1933\u20137. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-0347.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"2947_CR52","doi-asserted-by":"publisher","first-page":"E146","DOI":"10.1002\/ijc.29119","volume":"136","author":"L Mirabello","year":"2015","unstructured":"Mirabello L, Frimer M, Harari A, et al. HPV16 methyl-haplotypes determined by a novel next-generation sequencing method are associated with cervical precancer. Int J Cancer. 2015;136(4):E146\u201353. https:\/\/doi.org\/10.1002\/ijc.29119.","journal-title":"Int J Cancer"},{"key":"2947_CR53","unstructured":"CHEN Guandi, QIAN deying, CHEN Jianmin. The regression law of high risk human papilloma virus after treatment of High level cervical squamous intraepithelial lesions[ J]. Chinese Journal of Practical Gynecology and Obstetrics, 2011, 27(1): 42\u201344."},{"issue":"2","key":"2947_CR54","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ygyno.2011.07.032","volume":"123","author":"A Trop\u00e9","year":"2011","unstructured":"Trop\u00e9 A, Jonassen CM, Sj\u00f8borg KD, et al. Role of high-risk human papillomavirus (HPV) mrna testing in the prediction of residual disease after conisation for high-grade cervical intraepithelial neoplasia. Gynecol Oncol. 2011;123(2):257\u201362. https:\/\/doi.org\/10.1016\/j.ygyno.2011.07.032.","journal-title":"Gynecol Oncol"},{"key":"2947_CR55","doi-asserted-by":"publisher","unstructured":"M\u00f6ckel J, Clad A, Endres AS, Schneider V. 35te Tagung der Pathologen am Oberrhein\/35th Meeting of Pathologists of the Upper Rhine Region (PATOR) The Institute of Pathology, University Hospital Freiburg, Germany. 1 July 2006. Abstracts. Diagn Pathol. 2007;2 Suppl 1(Suppl 1):S1-S25. https:\/\/doi.org\/10.1186\/1746-1596-2-s1-s1. Epub 2007 Mar 14. PMID: 17430552; PMCID: PMC3226093.","DOI":"10.1186\/1746-1596-2-s1-s1"},{"key":"2947_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2021.101448","volume":"23","author":"G Weston","year":"2021","unstructured":"Weston G, Dombrowski C, Steben M, Popadiuk C, Bentley J, Adams EJ. A health economic model to estimate the costs and benefits of an mRNA vs DNA high-risk HPV assay in a hypothetical HPV primary screening algorithm in Ontario, Canada. Prev Med Rep. 2021;23:101448. https:\/\/doi.org\/10.1016\/j.pmedr.2021.101448. Published 2021 Jun 10.","journal-title":"Prev Med Rep"},{"key":"2947_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2024.101460","volume":"54","author":"S Reza","year":"2024","unstructured":"Reza S, Anjum R, Khandoker RZ, Khan SR, Islam MR, Dewan SMR. Public health concern-driven insights and response of low- and middle-income nations to the World Health Organization call for cervical cancer risk eradication. Gynecol Oncol Rep. 2024;54:101460. https:\/\/doi.org\/10.1016\/j.gore.2024.101460.","journal-title":"Gynecol Oncol Rep"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-025-02947-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-025-02947-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-025-02947-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T13:50:52Z","timestamp":1770645052000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13643-025-02947-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2947"],"URL":"https:\/\/doi.org\/10.1186\/s13643-025-02947-4","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"18 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval is not required for this study because we were only pool published data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}